MY191218A - Agent for improving early insulin secretory capacity - Google Patents

Agent for improving early insulin secretory capacity

Info

Publication number
MY191218A
MY191218A MYPI2017702472A MYPI2017702472A MY191218A MY 191218 A MY191218 A MY 191218A MY PI2017702472 A MYPI2017702472 A MY PI2017702472A MY PI2017702472 A MYPI2017702472 A MY PI2017702472A MY 191218 A MY191218 A MY 191218A
Authority
MY
Malaysia
Prior art keywords
agent
insulin secretory
secretory capacity
improving early
early insulin
Prior art date
Application number
MYPI2017702472A
Other languages
English (en)
Inventor
Yasuto Yoshida
Eiichiro Naito
Satoru Kunihiro
Kouji Miyazaki
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Publication of MY191218A publication Critical patent/MY191218A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
MYPI2017702472A 2015-01-22 2016-01-21 Agent for improving early insulin secretory capacity MY191218A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015010024 2015-01-22
PCT/JP2016/051732 WO2016117654A1 (ja) 2015-01-22 2016-01-21 インスリン初期分泌能改善剤

Publications (1)

Publication Number Publication Date
MY191218A true MY191218A (en) 2022-06-09

Family

ID=56417184

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017702472A MY191218A (en) 2015-01-22 2016-01-21 Agent for improving early insulin secretory capacity

Country Status (6)

Country Link
JP (1) JP6670256B2 (ja)
KR (1) KR102497887B1 (ja)
CN (1) CN107106619A (ja)
MY (1) MY191218A (ja)
SG (2) SG10201906475UA (ja)
WO (1) WO2016117654A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6999115B2 (ja) * 2016-10-28 2022-01-18 株式会社ヤクルト本社 無病率低下抑制剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0859492A (ja) 1994-08-26 1996-03-05 Yakult Honsha Co Ltd 抗糖尿病薬
JP2011193730A (ja) * 2010-03-17 2011-10-06 Yakult Honsha Co Ltd 多糖−ペプチドグリカン複合体保有乳酸菌の取得方法

Also Published As

Publication number Publication date
WO2016117654A1 (ja) 2016-07-28
JPWO2016117654A1 (ja) 2017-11-02
JP6670256B2 (ja) 2020-03-18
CN107106619A (zh) 2017-08-29
KR102497887B1 (ko) 2023-02-08
KR20170103774A (ko) 2017-09-13
SG10201906475UA (en) 2019-08-27
SG11201705174WA (en) 2017-07-28

Similar Documents

Publication Publication Date Title
MX2017016819A (es) Composiciones antimicrobianas y sus usos.
PH12017500408B1 (en) Heteroaryl compounds as btk inhibitors and uses thereof
EP3269378A4 (en) Composition for preventing or treating inflammatory diseases, comprising lactic acid bacteria-derived extracellular vesicles as active ingredients
MY195729A (en) Cell-Free Production of Ribonucleic Acid
AU2015279424A8 (en) Difluoromethyl-nicotinic-indanyl carboxamides
MX2021014663A (es) Il-23a y tnf-alfa orientados y compuesto y sus usos.
MX2018000050A (es) Fenoxihalogenofenilamidinas y su uso como fungicidas.
MX2023002516A (es) Composiciones bacterianas.
MX2016014235A (es) Biosintesis microbiana de ergotioneina.
MX2021000189A (es) Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias.
MX2018003554A (es) Benzamidas sustituidas con isoxazolina y analogos como insecticidas.
MX2016010451A (es) Benzoxaboroles microbicidamente activos.
MY193444A (en) Cell-free production of ribonucleic acid
EP4282272A3 (en) Method of delivering an agriculturally active ingredient
MX2015015162A (es) Agente de reduccion de acido urico.
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
CL2019002986A1 (es) Nuevo compuesto sólido cristalino clorhidrato de 3-fenil-4-propil-1-(piridin-2-il)-1h-pirazol-5-ol.
MX2017012073A (es) Compuestos de minociclina para biodefensas.
EP3222157A4 (en) Food composition, containing lactococcus strain as active ingredient, for alleviating hangover
PH12019500264A1 (en) Lactobacillus salivarius cjls1511, animal feed additive composition comprising same bacterium or dead cells thereof, and method for producing same dead cells
MY191081A (en) Compound targetting il-23a and b-cell activating factor (baff) and uses thereof
PH12018500069A1 (en) Novel lactobacillus sp. microorganisms, and composition for animal feed comprising same
EP3851517A4 (en) COMPOSITION FOR INHIBITING THE ACTIVITY OF TRYPSIN, CONTAINING, AS ACTIVE PRINCIPLE, A BACTERIA BELONGING TO THE GENUS PARAPREVOTELLA
MY191218A (en) Agent for improving early insulin secretory capacity
MX2016013439A (es) Formas solidas de un compuesto farmaceuticamente activo.